INSIDERFilingvia Quantisnow
Ionis Pharmaceuticals Inc. logo

Ionis Pharmaceuticals (IONS) director Hayden bought 15,000 shares for $478K at $31.86

ByQuantisnow··Wall Street's wire, on your screen.

Insider transactions reported

Michael R Hayden (director at Ionis Pharmaceuticals Inc., IONS) reported that they bought 15,000 shares for $478K at $31.86 on May 1, 2025. After these transactions the filing shows 50,219 shares held directly.

Reporting person
Hayden Michael R
Common stock and other non-derivative transactions
DateTypeSecuritySharesPriceValueHeld after
May 1, 2025Open-market purchase (P)Common Stock1+15,000$31.86$478K50,219 direct

Holdings before and after

  • Common Stock: 35,219 to 50,219 direct

Other positions listed

  • Common Stock: 2,000 indirect, by Spouse

Footnotes from the filing

  1. 1. The price reported in Column 4 is a weighted average price. These shares were purchase in multiple transactions at prices ranging from $31.50 to $32.09 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) on this Form 4.
  2. 2. These securities are held by Genworks 2 Consulting, Inc. ( Genworks 2 ). The Reporting Person's spouse has sole voting and investment power with respect to the shares held by Genworks 2.

Transaction codes in this filing

Open-market purchase:
Code P marks a purchase in the open market or a private deal. The insider paid for these securities.

FAQ

What did Hayden report in this IONS Form 4?

Michael R Hayden (director at Ionis Pharmaceuticals Inc., IONS) reported that they bought 15,000 shares for $478K at $31.86 on May 1, 2025. After these transactions the filing shows 50,219 shares held directly.

How many IONS shares does Hayden hold after this filing?

The filing shows 50,219 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.

What does transaction code P mean on an SEC Form 4?

Code P marks a purchase in the open market or a private deal. The insider paid for these securities.

Ask Ellis, your AI research assistant, about this story

Historical context for IONS

Earlier insider filings at IONS

Keep researching IONS

Our reporting on IONS

Quantisnow market dataNASDAQ
Ionis Pharmaceuticals Inc. logo
IONS
Ionis Pharmaceuticals Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Get push alerts for IONS

Follow IONS and get a push notification the moment its next story breaks.

Full IONS profile on Quantisnow

Watch IONS for work, on its IR, comms or brand team or at an agency? Send every IONS item and its competitors' to your team's Slack or Teams.

Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IONS (Ionis Pharmaceuticals Inc.) and more on Quantisnow.